Skip to main content
. 2021 Feb 9;9(2):171. doi: 10.3390/biomedicines9020171

Figure 3.

Figure 3

(A): Adenosquamous squamous cell carcinoma. Hematoxylin and eosin, 200×. (B): Perineural squamous cell carcinoma. Hematoxylin and eosin, 100×. (C): Papillary squamous cell carcinoma. Hematoxylin and eosin, 40×.